Tag: https://www.bio.org/events/bio-international-convention

Apr 29
US Senate Committee on Finance – Hearing on Drug Price Controls

Stephen Ezell, Vice President, Global Innovation Policy, Information Technology and Innovation Foundation and Douglas … source

Apr 28
Dr. Cartier Esham, Opening Statement – Testimony at the House Energy & Commerce Health Subcommittee

BIO’s Chief Scientific Officer, Dr. Cartier Esham’s opening statement at the House Energy & Commerce Health Subcommittee … source

Apr 27
Dr. Cartier Esham – Highlights – Testimony at House Energy & Commerce Health Subcommittee Hearing

Highlights of BIO’s Chief Scientific Officer, Dr. Cartier Esham’s testimony at the House Energy & Commerce Health Subcommittee … source

Apr 26
Sabrina Martucci Johnson, CEO, Daré Bioscience-2022 BIO International Convention is Back in Person!

For the first time in two years, the BIO International Convention will be back fully in person, from June 13-16 in San Diego, CA. Join us to explore ‘LIMITLESS’ possibilities and seize today’s unprecedented momentum to realize a biotech-driven future where we can cure disease, and create a healthier world through science. The BIO International […]

Apr 25
Dr. McMurry-Heath, South Carolina Bio (SCBio) 2022

Dr. McMurry-Heath gave an inspiring keynote address at South Carolina Bio’s (SCBio) 2022 Annual Meeting. The theme of the … source

Apr 24
John Crowley, Amicus Therapeutic's CEO – 2022 BIO International Convention is Back in Person!

For the first time in two years, the BIO International Convention will be back fully in person, from June 13-16 in San Diego, CA. source

Apr 23
Phyllis Arthur – SmartBrief Panel – The Life Sciences Supply Chain Struggle – March 24, 2022

Phyllis Arthur, Vice President of Infectious Diseases and Diagnostics Policy at BIO, participates in the SmartBrief panel discussion, … source

Apr 22
Phyllis Arthur – POLITICO's Inaugural Health Care Summit – The Many Legacies of Covid

Phyllis Arthur, Vice President, Infectious Diseases and Diagnostics Policy, BIO, participated on a panel discussion, “The Many … source

Apr 21
Scott DeWire, Head of Business Development & Licensing USA, Boehringer-Ingelheim – BIO2022

2022 BIO International Convention is Back in Person! For the first time in two years, the BIO International Convention will be back … source

Apr 20
Dr. Cartier Esham's Testimony at the Senate Committee on Health, Education, Labor & Pensions Hearing

Highlights of BIO’s Chief Scientific Officer, Dr. Cartier Esham’s testimony at the U.S. Senate Committee on Health, Education, Labor and Pensions Hearing, “FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients,” on April 5, 2022. source